271 related articles for article (PubMed ID: 36497265)
1. Staging Breast Cancer with MRI, the T. A Key Role in the Neoadjuvant Setting.
Panico C; Ferrara F; Woitek R; D'Angelo A; Di Paola V; Bufi E; Conti M; Palma S; Cicero SL; Cimino G; Belli P; Manfredi R
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497265
[TBL] [Abstract][Full Text] [Related]
2. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of digital mammography, ultrasound and MRI in predicting the pathological complete response and residual tumor size of breast cancer after completion of neoadjuvant chemotherapy.
Sudhir R; Koppula VC; Rao TS; Sannapareddy K; Rajappa SJ; Murthy SS
Indian J Cancer; 2022; 59(3):345-353. PubMed ID: 33753611
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
Zhu M; Liang C; Zhang F; Zhu L; Chen D
Front Oncol; 2021; 11():690336. PubMed ID: 34745934
[TBL] [Abstract][Full Text] [Related]
6. Surgical Planning after Neoadjuvant Treatment in Breast Cancer: A Multimodality Imaging-Based Approach Focused on MRI.
Conti M; Morciano F; Bufi E; D'Angelo A; Panico C; Di Paola V; Gori E; Russo G; Cimino G; Palma S; Belli P; Manfredi R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900231
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study.
Skarping I; Förnvik D; Heide-Jørgensen U; Rydén L; Zackrisson S; Borgquist S
Acta Oncol; 2020 Dec; 59(12):1528-1537. PubMed ID: 33063567
[TBL] [Abstract][Full Text] [Related]
8. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
[TBL] [Abstract][Full Text] [Related]
9. Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.
Pesapane F; Rotili A; Botta F; Raimondi S; Bianchini L; Corso F; Ferrari F; Penco S; Nicosia L; Bozzini A; Pizzamiglio M; Origgi D; Cremonesi M; Cassano E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503081
[TBL] [Abstract][Full Text] [Related]
10. Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.
Haussmann J; Budach W; Nestle-Krämling C; Wollandt S; Tamaskovics B; Corradini S; Bölke E; Krug D; Fehm T; Ruckhäberle E; Audretsch W; Jazmati D; Matuschek C
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011025
[TBL] [Abstract][Full Text] [Related]
11. Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).
Agrawal S; Banswal L; Saha A; Arun I; Datta SS; Chatterjee S; Ahmed R
Indian J Surg Oncol; 2016 Dec; 7(4):397-406. PubMed ID: 27872526
[TBL] [Abstract][Full Text] [Related]
12. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.
Huang Y; Chen W; Zhang X; He S; Shao N; Shi H; Lin Z; Wu X; Li T; Lin H; Lin Y
Front Bioeng Biotechnol; 2021; 9():662749. PubMed ID: 34295877
[No Abstract] [Full Text] [Related]
14. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).
Fayanju OM; Ren Y; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Tamirisa N; Force J; Boughey JC; Hyslop T; Hwang ES
Ann Surg; 2018 Oct; 268(4):591-601. PubMed ID: 30048319
[TBL] [Abstract][Full Text] [Related]
16. Management of the Axilla and the Breast After Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review.
Citgez B; Yigit B; Yetkin SG
Sisli Etfal Hastan Tip Bul; 2021; 55(2):156-161. PubMed ID: 34349589
[TBL] [Abstract][Full Text] [Related]
17. Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.
Weiss A; Bashour SI; Hess K; Thompson AM; Ibrahim NK
Breast Cancer Res; 2018 Apr; 20(1):27. PubMed ID: 29661243
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of change in tumor stiffness measured by acoustic radiation force impulse imaging for early prediction of response to neoadjuvant chemotherapy in breast cancer.
Mahadevan GSV; Chakkalakkoombil SV; Kayal S; Dharanipragada K; Toi PC; Ananthakrishnan R
J Clin Ultrasound; 2022 Jun; 50(5):666-674. PubMed ID: 35353384
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant Setting.
Palshof FK; Lanng C; Kroman N; Benian C; Vejborg I; Bak A; Talman ML; Balslev E; Tvedskov TF
Ann Surg Oncol; 2021 Nov; 28(12):7421-7429. PubMed ID: 34043094
[TBL] [Abstract][Full Text] [Related]
20. Is magnetic resonance imaging useful in early evaluation of women on neoadjuvant chemotherapy for locally advanced cervical cancer?
Sala P; Marchiolè P; Cittadini G; Valenzano Menada M; Moioli M; Mammoliti S; Costantini S
Eur J Gynaecol Oncol; 2012; 33(1):31-6. PubMed ID: 22439402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
